progress Facilitating industry progress By www.eversheds.com Published On :: 2017-11-14 ... Full Article
progress China's progress on business resumption on May 9 By article.wn.com Published On :: Sat, 09 May 2020 13:59 GMT BEIJING - Amid the further containment of the novel coronavirus disease (COVID-19), China is powering ahead in returning to work and resuming business and production. The following are the latest facts and figures: - China is set to orderly open up public places and entertainment venues, according to a guideline issued by the State Council on May 8. Shopping malls, supermarkets, hotels, restaurants and... Full Article
progress Coronavirus: scientists say US-China ‘political drama’ is impeding progress on tracing Covid-19’s path By www.scmp.com Published On :: Sat, 09 May 2020 06:02:58 +0800 US government requests from China for early coronavirus samples make sense as part of efforts to bring the pandemic under control and avoid future ones, but the “political drama” around the efforts is undermining progress, two public health experts warned.RNA viruses like Sars-CoV-2, the coronavirus that causes Covid-19, mutate about once a month, making them “essentially a clock that enables one to extrapolate when the virus actually evolved”, said Dr Barry Bloom, an infectious disease… Full Article
progress Has COVID-19 Reversed Progress for India’s Small Tea Growers? By www.ipsnews.net Published On :: Mon, 04 May 2020 14:12:34 +0000 As the sun sets over the hills, Prafulla Debbarma, a small tea grower in Dhanbilash village in north eastern India, walks along the labyrinth path of his farm and past a thick blanket of well-grown tea plants. In the fading light, the farmer appears deeply worried. This tea farm, the sole source of his livelihood, […] The post Has COVID-19 Reversed Progress for India’s Small Tea Growers? appeared first on Inter Press Service. Full Article Asia-Pacific Development & Aid Economy & Trade Featured Food & Agriculture Headlines Poverty & SDGs Regional Categories Sustainability TerraViva United Nations Trade & Investment Coronavirus COVID-19 India Tea Estates tea growers Tripura
progress May nothing, no one, derail our progress toward integration By www.granma.cu Published On :: Sun, 14 Dec 2014 14:48:01 -0800 Cuban President Army General Raúl Castro Ruz opened the XIII Summit of the Bolivarian Alliance for the Peoples of Our America-People's Trade Agreement (Alba-TCP), this morning December 14, and called for strengthening regional unity. - ALBA to celebrate 20th anniversary in Havana Full Article
progress PMAY progress report: Centre approves 93 percent of total housing units By www.indianrealtynews.com Published On :: Tue, 24 Mar 2020 20:11:07 +0000 The Central Government has approved around 93 percent of the total planned housing units under the Pradhan Mantri Awas Yojana-Urban (PMAY-U). By far, as many as 1.03 crore housing units have been sanctioned across the country under the said scheme. To provide affordable pucca houses to the homeless population of the country, the Central Government has approved over 1 crore houses in urban parts of the country under the Pradhan Mantri Awas Yojana – Urban (PMAY-U). Against the humongous target of 1.2 crore units, the Government has sanctioned nearly 1.03 crore units across the States and Union Territories (UTs). Of the approved units, approximately 61 lakh units are under-construction and nearly […] Full Article Real Estate India
progress Revisiting the Public–Private Partnership for Rapid Progress on the Sanitation-Related Sustainable Development Goals By feedproxy.google.com Published On :: 2020-05-08 00:00:00 Providing safely managed sanitation services for all requires extending the partnership between the public and private sectors. Full Article Publication
progress Revisiting the Public–Private Partnership for Rapid Progress on the Sanitation-Related Sustainable Development Goals By feedproxy.google.com Published On :: 2020-05-08 00:00:00 Providing safely managed sanitation services for all requires extending the partnership between the public and private sectors. Full Article Publication
progress Revisiting the Public–Private Partnership for Rapid Progress on the Sanitation-Related Sustainable Development Goals By feedproxy.google.com Published On :: 2020-05-08 00:00:00 Providing safely managed sanitation services for all requires extending the partnership between the public and private sectors. Full Article
progress Revisiting the Public–Private Partnership for Rapid Progress on the Sanitation-Related Sustainable Development Goals By www.adb.org Published On :: 2020-05-08 00:00:00 Providing safely managed sanitation services for all requires extending the partnership between the public and private sectors. Full Article
progress Progress in Predicting Invasive Breast Cancer By www.medicinenet.com Published On :: Sat, 9 May 2020 00:00:00 PDT Title: Progress in Predicting Invasive Breast CancerCategory: Health NewsCreated: 4/29/2010 10:21:00 AMLast Editorial Review: 4/29/2010 10:21:45 AM Full Article
progress Vitamin E does not prevent Western diet-induced NASH progression and increases metabolic flux dysregulation in mice [Research Articles] By www.jlr.org Published On :: 2020-05-01T00:05:27-07:00 Fatty liver involves ectopic lipid accumulation and dysregulated hepatic oxidative metabolism, which can progress to a state of elevated inflammation and fibrosis referred to as nonalcoholic steatohepatitis (NASH). The factors that control progression from simple steatosis to NASH are not fully known. Here, we tested the hypothesis that dietary vitamin E (VitE) supplementation would prevent NASH progression and associated metabolic alterations induced by a Western diet (WD). Hyperphagic melanocortin-4 receptor-deficient (MC4R–/–) mice were fed chow, chow+VitE, WD, or WD+VitE starting at 8 or 20 weeks of age. All groups exhibited extensive hepatic steatosis by the end of the study (28 weeks of age). WD feeding exacerbated liver disease severity without inducing proportional changes in liver triglycerides. Eight weeks of WD accelerated liver pyruvate cycling, and 20 weeks of WD extensively upregulated liver glucose and oxidative metabolism assessed by 2H/13C flux analysis. VitE supplementation failed to reduce the histological features of NASH. Rather, WD+VitE increased the abundance and saturation of liver ceramides and accelerated metabolic flux dysregulation compared with 8 weeks of WD alone. In summary, VitE did not limit NASH pathogenesis in genetically obese mice, but instead increased some indicators of metabolic dysfunction. Full Article
progress Lipid rafts as signaling hubs in cancer cell survival/death and invasion: implications in tumor progression and therapy [Thematic Reviews] By www.jlr.org Published On :: 2020-05-01T00:05:27-07:00 Cholesterol/sphingolipid-rich membrane domains, known as lipid rafts or membrane rafts, play a critical role in the compartmentalization of signaling pathways. Physical segregation of proteins in lipid rafts may modulate the accessibility of proteins to regulatory or effector molecules. Thus, lipid rafts serve as sorting platforms and hubs for signal transduction proteins. Cancer cells contain higher levels of intracellular cholesterol and lipid rafts than their normal non-tumorigenic counterparts. Many signal transduction processes involved in cancer development (insulin-like growth factor system and phosphatidylinositol 3-kinase-AKT) and metastasis [cluster of differentiation (CD)44] are dependent on or modulated by lipid rafts. Additional proteins playing an important role in several malignant cancers (e.g., transmembrane glycoprotein mucin 1) are also being detected in association with lipid rafts, suggesting a major role of lipid rafts in tumor progression. Conversely, lipid rafts also serve as scaffolds for the recruitment and clustering of Fas/CD95 death receptors and downstream signaling molecules leading to cell death-promoting raft platforms. The partition of death receptors and downstream signaling molecules in aggregated lipid rafts has led to the formation of the so-called cluster of apoptotic signaling molecule-enriched rafts, or CASMER, which leads to apoptosis amplification and can be pharmacologically modulated. These death-promoting rafts can be viewed as a linchpin from which apoptotic signals are launched. In this review, we discuss the involvement of lipid rafts in major signaling processes in cancer cells, including cell survival, cell death, and metastasis, and we consider the potential of lipid raft modulation as a promising target in cancer therapy. Full Article
progress North Carolina's Health Care Transformation to Value: Progress to Date and Further Steps Needed By www.ncmedicaljournal.com Published On :: 2020-05-04T06:50:30-07:00 North Carolina has received national attention for its approach to health care payment and delivery reform. Importantly, payment reform alone is not enough to drive systematic changes in care delivery. We highlight the importance of progress in four complementary areas to achieve system-wide payment and care reform. Full Article
progress Progressive supranuclear palsy and pawpaw By cp.neurology.org Published On :: 2020-04-06T12:45:20-07:00 Consider consumption of annonacin-containing plant products, including pawpaw, as a possible environmental risk factor for atypical parkinsonism. Full Article
progress E2F6-Mediated Downregulation of MIR22HG Facilitates the Progression of Laryngocarcinoma by Targeting the miR-5000-3p/FBXW7 Axis [Research Article] By mcb.asm.org Published On :: 2020-04-28T08:00:17-07:00 Recently, abundant evidence has clarified that long noncoding RNAs (lncRNAs) play an oncogenic or anticancer role in the tumorigenesis and development of diverse human cancers. Described as a crucial regulator in some cancers, MIR22HG has not yet been studied in laryngocarcinoma and therefore the underlying regulatory role of MIR22HG in laryngocarcinoma is worth detecting. In this study, MIR22HG expression in laryngocarcinoma cells was confirmed to be downregulated, and upregulated MIR22HG expression led to suppressive effects on laryngocarcinoma cell proliferation and migration. Molecular mechanism assays revealed that MIR22HG sponges miR-5000-3p in laryngocarcinoma cells. Besides, decreased expression of miR-5000-3p suppressed laryngocarcinoma cell proliferation and migration. Moreover, the FBXW7 gene was reported to be a downstream target gene of miR-5000-3p in laryngocarcinoma cells. More importantly, rescue assays verified that FBXW7 depletion or miR-5000-3p upregulation countervailed the repressive effects of MIR22HG overexpression on laryngocarcinoma progression. In addition, E2F6 was proved to be capable of inhibiting MIR22HG transcription in laryngocarcinoma cells. To sum up, E2F6-induced downregulation of MIR22HG promotes laryngocarcinoma progression through the miR-5000-3p/FBXW7 axis. Full Article
progress AKT Regulates Mitotic Progression of Mammalian Cells by Phosphorylating MASTL, Leading to Protein Phosphatase 2A Inactivation [Research Article] By mcb.asm.org Published On :: 2020-04-28T08:00:17-07:00 Microtubule-associated serine/threonine kinase like (MASTL), also known as Greatwall (Gwl) kinase, has an important role in the regulation of mitosis. By inhibiting protein phosphatase 2A (PP2A), it plays a crucial role in activating one of the most important mitotic kinases, known as cyclin-dependent kinase 1 (CDK1). MASTL has been seen to be upregulated in various types of cancers and is also involved in tumor recurrence. It is activated by CDK1 through phosphorylations in the activation/T-loop, but the complete mechanism of its activation is still unclear. Here, we report that AKT phosphorylates MASTL at residue T299, which plays a critical role in its activation. Our results suggest that AKT increases CDK1-mediated phosphorylation and hence the activity of MASTL, which, in turn, promotes mitotic progression through PP2A inhibition. We also show that the oncogenic potential of AKT is augmented by MASTL activation, since AKT-mediated proliferation in colorectal cell lines can be attenuated by inhibiting and/or silencing MASTL. In brief, we report that AKT plays an important role in the progression of mitosis in mammalian cells and that it does so through the phosphorylation and activation of MASTL. Full Article
progress Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children By jasn.asnjournals.org Published On :: 2020-04-30T10:00:30-07:00 Background After accounting for known risk factors for CKD progression in children, clinical outcomes among children with CKD still vary substantially. Biomarkers of tubular injury (such as KIM-1), repair (such as YKL-40), or inflammation (such as MCP-1, suPAR, TNF receptor-1 [TNFR-1], and TNFR-2) may identify children with CKD at risk for GFR decline. Methods We investigated whether plasma KIM-1, YKL-40, MCP-1, suPAR, TNFR-1, and TNFR-2 are associated with GFR decline in children with CKD and in subgroups defined by glomerular versus nonglomerular cause of CKD. We studied participants of the prospective CKiD Cohort Study which enrolled children with an eGFR of 30–90 ml/min per 1.73 m2 and then assessed eGFR annually. Biomarkers were measured in plasma collected 5 months after study enrollment. The primary endpoint was CKD progression, defined as a composite of a 50% decline in eGFR or incident ESKD. Results Of the 651 children evaluated (median age 11 years; median baseline eGFR of 53 ml/min per 1.73 m2), 195 (30%) had a glomerular cause of CKD. Over a median follow-up of 5.7 years, 223 children (34%) experienced CKD progression to the composite endpoint. After multivariable adjustment, children with a plasma KIM-1, TNFR-1, or TNFR-2 concentration in the highest quartile were at significantly higher risk of CKD progression compared with children with a concentration for the respective biomarker in the lowest quartile (a 4-fold higher risk for KIM-1 and TNFR-1 and a 2-fold higher risk for TNFR-2). Plasma MCP-1, suPAR, and YKL-40 were not independently associated with progression. When stratified by glomerular versus nonglomerular etiology of CKD, effect estimates did not differ significantly. Conclusions Higher plasma KIM-1, TNFR-1, and TNFR-2 are independently associated with CKD progression in children. Full Article
progress The progressive development of microfabrics from initial deposition to slump deformation: an example from a modern sedimenary melange on the Nankai Prism By jgs.lyellcollection.org Published On :: 2020-05-04T02:10:48-07:00 The progressive development of microfabrics from initial deposition to slump deformation and then a submarine slide was investigated in an active subduction zone using cores recovered during the Integrated Ocean Drilling Program Expedition 333. A Pleistocene–Holocene sequence was recovered at Site C0018A, which was located on a slope basin on the footwall of the megasplay fault in the Nankai Trough, SW Japan. Six mass-transport deposit units intercalated with coherent intervals were recovered from the upper 190 m of the drilled succession. The initial microfabrics in the undeformed hemipelagic sediments were characterized by random and porous fabrics composed predominantly of clay aggregations and connectors. The initial fabrics were cardhouse fabrics, which consist of clay flakes with edge-to-edge (E–E) and/or edge-to-face (E–F) contacts. These initial microfabrics developed into compacted microfabrics, which are random and consolidated fabrics (bookhouse fabrics) that consist of clay flakes with E–F and/or face-to-face (F–F) contacts and develop during burial as a pure shear deformation. During slumping, these fabrics were then deformed under simple shear to become predominantly F–F contacts and form clay chains. Thus, the microfabrics in these submarine slides are a sedimentary mélange that developed locally into a preferred clay orientation with F–F contacts. Supplementary material: A schematic illustration showing sedimentation processes and fabrics is available at https://doi.org/10.6084/m9.figshare.c.4483385 Thematic collection: This article is part of the Polygenetic mélanges collection available at: https://www.lyellcollection.org/cc/polygenetic-melanges Full Article
progress Progress toward Development of a Vaccine against Congenital Cytomegalovirus Infection [Minireviews] By cvi.asm.org Published On :: 2017-12-05T08:00:30-08:00 A vaccine against congenital human cytomegalovirus (CMV) infection is a major public health priority. Congenital CMV causes substantial long-term morbidity, particularly sensorineural hearing loss (SNHL), in newborns, and the public health impact of this infection on maternal and child health is underrecognized. Although progress toward development of a vaccine has been limited by an incomplete understanding of the correlates of protective immunity for the fetus, knowledge about some of the key components of the maternal immune response necessary for preventing transplacental transmission is accumulating. Moreover, although there have been concerns raised about observations indicating that maternal seropositivity does not fully prevent recurrent maternal CMV infections during pregnancy, it is becoming increasing clear that preconception immunity does confer some measure of protection against both CMV transmission and CMV disease (if transmission occurs) in the newborn infant. Although the immunity to CMV conferred by both infection and vaccination is imperfect, there are encouraging data emerging from clinical trials demonstrating the immunogenicity and potential efficacy of candidate CMV vaccines. In the face of the knowledge that between 20,000 and 30,000 infants are born with congenital CMV in the United States every year, there is an urgent and compelling need to accelerate the pace of vaccine trials. In this minireview, we summarize the status of CMV vaccines in clinical trials and provide a perspective on what would be required for a CMV immunization program to become incorporated into clinical practice. Full Article
progress Histone Demethylase JMJD1A Promotes Tumor Progression via Activating Snail in Prostate Cancer By mcr.aacrjournals.org Published On :: 2020-05-04T05:40:21-07:00 The histone demethylase JMJD1A plays a key functional role in spermatogenesis, sex determination, stem cell renewal, and cancer via removing mono- and di-methyl groups from H3K9 to epigenetically control gene expression. However, its role in prostate cancer progression remains unclear. Here, we found JMJD1A was significantly elevated in prostate cancer tissue compared with matched normal tissue. Ectopic JMJD1A expression in prostate cancer cells promoted proliferation, migration, and invasion in vitro, and tumorigenesis in vivo; JMJD1A knockdown exhibited the opposite effects. Mechanically, we revealed that JMJD1A directly interacted with the Snail gene promoter and regulated its transcriptional activity, promoting prostate cancer progression both in vitro and in vivo. Furthermore, we found that JMJD1A transcriptionally activated Snail expression via H3K9me1 and H3K9me2 demethylation at its special promoter region. In summary, our studies reveal JMJD1A plays an important role in regulating proliferation and progression of prostate cancer cells though Snail, and thus highlight JMJD1A as potential therapeutic target for advanced prostate cancer. Implications: Our studies identify that JMJD1A promotes the proliferation and progression of prostate cancer cells through enabling Snail transcriptional activation, and thus highlight JMJD1A as potential therapeutic target for advanced prostate cancer. Full Article
progress Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution [Review Articles] By pharmrev.aspetjournals.org Published On :: 2020-03-20T10:40:35-07:00 Before it was molecularly cloned in 1994, acute-phase response factor or signal transducer and activator of transcription (STAT)3 was the focus of intense research into understanding the mammalian response to injury, particularly the acute-phase response. Although known to be essential for liver production of acute-phase reactant proteins, many of which augment innate immune responses, molecular cloning of acute-phase response factor or STAT3 and the research this enabled helped establish the central function of Janus kinase (JAK) family members in cytokine signaling and identified a multitude of cytokines and peptide hormones, beyond interleukin-6 and its family members, that activate JAKs and STAT3, as well as numerous new programs that their activation drives. Many, like the acute-phase response, are adaptive, whereas several are maladaptive and lead to chronic inflammation and adverse consequences, such as cachexia, fibrosis, organ dysfunction, and cancer. Molecular cloning of STAT3 also enabled the identification of other noncanonical roles for STAT3 in normal physiology, including its contribution to the function of the electron transport chain and oxidative phosphorylation, its basal and stress-related adaptive functions in mitochondria, its function as a scaffold in inflammation-enhanced platelet activation, and its contributions to endothelial permeability and calcium efflux from endoplasmic reticulum. In this review, we will summarize the molecular and cellular biology of JAK/STAT3 signaling and its functions under basal and stress conditions, which are adaptive, and then review maladaptive JAK/STAT3 signaling in animals and humans that lead to disease, as well as recent attempts to modulate them to treat these diseases. In addition, we will discuss how consideration of the noncanonical and stress-related functions of STAT3 cannot be ignored in efforts to target the canonical functions of STAT3, if the goal is to develop drugs that are not only effective but safe. Significance Statement Key biological functions of Janus kinase (JAK)/signal transducer and activator of transcription (STAT)3 signaling can be delineated into two broad categories: those essential for normal cell and organ development and those activated in response to stress that are adaptive. Persistent or dysregulated JAK/STAT3 signaling, however, is maladaptive and contributes to many diseases, including diseases characterized by chronic inflammation and fibrosis, and cancer. A comprehensive understanding of JAK/STAT3 signaling in normal development, and in adaptive and maladaptive responses to stress, is essential for the continued development of safe and effective therapies that target this signaling pathway. Full Article
progress Proposal for Systemic-Therapy Response-Assessment Criteria at the Time of PSMA PET/CT Imaging: The PSMA PET Progression Criteria By jnm.snmjournals.org Published On :: 2020-05-01T06:31:37-07:00 In around 20% of men with prostate cancer, metastasis develops during the course of their disease. Accordingly, discovering and developing new potent treatment strategies for patients with metastatic prostate cancer has been a major research focus during the last few decades. Identifying disease progression, especially within clinical trials, is essential in determining drug effectiveness. One major remaining question is how best to define disease progression. The criteria of the Prostate Cancer Clinical Trials Working Group (PCWG2) include clinical and laboratory parameters, as well as conventional imaging modalities such as MRI, CT, and bone scan findings, but advanced molecular imaging techniques, especially prostate-specific membrane antigen (PSMA) PET findings, are not considered. This is a problem because PSMA PET is used not only for detecting biochemical recurrence but also for restaging and as an intermediate-endpoint biomarker in ongoing clinical trials. Therefore, response criteria and PSMA PET progression (PPP) criteria need to be established with some urgency. The intent of this article is therefore to define prostate cancer progression by PSMA PET criteria. Our PPP proposal is based on the same principles as were applied for the PCGW2 criteria but adds value by including PSMA PET criteria. PPP defines PSMA treatment response using 3 different criteria. The first is the appearance of 2 or more new PSMA-positive distant lesions. The second is the appearance of 1 new PSMA-positive lesion plus consistent clinical or laboratory data and recommended confirmation by biopsy or correlative imaging within 3 mo of PSMA PET. The third is an increase in size or PSMA uptake of 1 or more existing lesions by at least 30%, plus consistent clinical or laboratory data or confirmation by biopsy or correlative imaging within 3 mo of PSMA PET. Full Article
progress Case 1: Progressive Dysphagia in a Teenager with Down Syndrome By pedsinreview.aappublications.org Published On :: 2020-05-01T01:00:19-07:00 Full Article
progress Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
progress An increase in MYC copy number has a progressive negative prognostic impact in patients with diffuse large B-cell and high-grade lymphoma, who may benefit from intensified treatment regimens By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 MYC translocations, a hallmark of Burkitt lymphoma, occur in 5-15% of diffuse large B-cell lymphoma, and have a negative prognostic impact. Numerical aberrations of MYC have also been detected in these patients, but their incidence and prognostic role are still controversial. We analyzed the clinical impact of MYC increased copy number on 385 patients with diffuse large B-cell lymphoma screened at diagnosis for MYC, BCL2, and BCL6 rearrangements. We enumerated the number of MYC copies, defining as amplified those cases with an uncountable number of extra-copies. The prevalence of MYC translocation, increased copy number and amplification was 8.8%, 15%, and 1%, respectively. Patients with 3 or 4 gene copies, accounting for more than 60% of patients with MYC copy number changes, had a more favorable outcome compared to patients with >4 copies or translocation of MYC, and were not influenced by the type of treatment received as first-line. Stratification according to the number of MYC extra-copies showed a negative correlation between an increasing number of copies and survival. Patients with >7 copies or the amplification of MYC had the poorest prognosis. Patients with >4 copies of MYC showed a similar, trending towards worse prognosis compared to patients with MYC translocation. The survival of patients with >4 copies, translocation or amplification of MYC seemed to be superior if intensive treatments were used. Our study underlines the importance of fluorescence in situ hybridization testing at diagnosis of diffuse large B-cell lymphoma to detect the rather frequent and clinically significant numerical aberrations of MYC. Full Article
progress CRISPR/Cas9-mediated gene deletion efficiently retards the progression of Philadelphia-positive acute lymphoblastic leukemia in a p210 BCR-ABL1T315I mutation mouse model By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
progress Disease progression in myeloproliferative neoplasms: comparing patients in accelerated phase with those in chronic phase with increased blasts (<10%) or with other types of disease progression By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
progress Suppressive effects of anagrelide on cell cycle progression and the maturation of megakaryocyte progenitor cell lines in human induced pluripotent stem cells By www.haematologica.org Published On :: 2020-05-01T00:05:42-07:00 Full Article
progress Impairment in Baroreflex Sensitivity in Recent-Onset Type 2 Diabetes Without Progression Over 5 Years By diabetes.diabetesjournals.org Published On :: 2020-04-20T12:00:34-07:00 Impaired baroreflex sensitivity (BRS) predicts cardiovascular mortality and is prevalent in long-term diabetes. We determined spontaneous BRS in patients with recent-onset diabetes and its temporal sequence over 5 years by recording beat-to-beat blood pressure and R-R intervals over 10 min. Four time domain and four frequency domain BRS indices were computed in participants from the German Diabetes Study baseline cohort with recent-onset type 1/type 2 diabetes (n = 206/381) and age-matched glucose-tolerant control subjects (control 1/control 2: n = 65/83) and subsets of consecutive participants with type 1/type 2 diabetes who reached the 5-year follow-up (n = 84/137). Insulin sensitivity (M-value) was determined using a hyperinsulinemic-euglycemic clamp. After appropriate adjustment, three frequency domain BRS indices were reduced in type 2 diabetes compared with control 2 and were positively associated with the M-value and inversely associated with fasting glucose and HbA1c (P < 0.05), whereas BRS was preserved in type 1 diabetes. After 5 years, a decrease in one and four BRS indices was observed in patients with type 1 and type 2 diabetes, respectively (P < 0.05), which was explained by the physiologic age-dependent decline. Unlike patients with well-controlled recent-onset type 1 diabetes, those with type 2 diabetes show early baroreflex dysfunction, likely due to insulin resistance and hyperglycemia, albeit without progression over 5 years. Full Article
progress Proteomic Analysis of CSF from Patients with Leptomeningeal Melanoma Metastases Identifies Signatures Associated with Disease Progression and Therapeutic Resistance By clincancerres.aacrjournals.org Published On :: 2020-05-01T00:05:36-07:00 Purpose: The development of leptomeningeal melanoma metastases (LMM) is a rare and devastating complication of the late-stage disease, for which no effective treatments exist. Here, we performed a multi-omics analysis of the cerebrospinal fluid (CSF) from patients with LMM to determine how the leptomeningeal microenvironment shapes the biology and therapeutic responses of melanoma cells. Experimental Design: A total of 45 serial CSF samples were collected from 16 patients, 8 of these with confirmed LMM. Of those with LMM, 7 had poor survival (<4 months) and one was an extraordinary responder (still alive with survival >35 months). CSF samples were analyzed by mass spectrometry and incubated with melanoma cells that were subjected to RNA sequencing (RNA-seq) analysis. Functional assays were performed to validate the pathways identified. Results: Mass spectrometry analyses showed the CSF of most patients with LMM to be enriched for pathways involved in innate immunity, protease-mediated damage, and IGF-related signaling. All of these were anticorrelated in the extraordinary responder. RNA-seq analysis showed CSF to induce PI3K/AKT, integrin, B-cell activation, S-phase entry, TNFR2, TGFβ, and oxidative stress responses in the melanoma cells. ELISA assays confirmed that TGFβ expression increased in the CSF of patients progressing with LMM. CSF from poorly responding patients conferred tolerance to BRAF inhibitor therapy in apoptosis assays. Conclusions: These analyses identified proteomic/transcriptional signatures in the CSF of patients who succumbed to LMM. We further showed that the CSF from patients with LMM has the potential to modulate BRAF inhibitor responses and may contribute to drug resistance. See related commentary by Glitza Oliva and Tawbi, p. 2083 Full Article
progress Efficacy and Safety of Duvelisib Following Disease Progression on Ofatumumab in Patients with Relapsed/Refractory CLL or SLL in the DUO Crossover Extension Study By clincancerres.aacrjournals.org Published On :: 2020-05-01T00:05:36-07:00 Purpose: In the phase III DUO trial, duvelisib, an oral dual PI3K-, inhibitor, demonstrated significantly improved efficacy versus ofatumumab [median (m) progression-free survival (PFS), 13.3 vs. 9.9 months (HR, 0.52; P < 0.0001); overall response rate [ORR], 74% vs. 45% (P < 0.0001)], with a manageable safety profile in patients with relapsed/refractory (R/R) chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). We report results from patients with progressive disease (PD) after ofatumumab who crossed over to duvelisib in the DUO trial. Patients and Methods: Patients with radiographically confirmed PD after ofatumumab received duvelisib 25 mg twice daily in 28-day cycles until PD, intolerance, death, or study withdrawal. The primary endpoint was ORR per investigator. Secondary endpoints included duration of response (DOR), PFS, and safety. Results: As of December 14, 2018, 90 ofatumumab-treated patients in the DUO trial prior to crossover had an ORR of 29%, mDOR of 10.4 months, and mPFS of 9.4 months. After crossover, 77% of patients (69/90) achieved a response, with an mDOR of 14.9 months and mPFS of 15.7 months. Patients with del(17p) and/or TP53 mutations had similar outcomes [ORR, 77% (20/26); mPFS, 14.7 months]. Notably, 73% of patients (47/64) with disease previously refractory to ofatumumab achieved a response. The most frequent any-grade/grade 3/4 treatment-emergent adverse events were diarrhea (47%/23%), neutropenia (26%/23%), pyrexia (24%/4%), cutaneous reactions (23%/4%), and thrombocytopenia (10%/6%). Conclusions: Duvelisib demonstrated high response rates with good durability and a manageable safety profile in patients with R/R CLL/SLL who progressed on ofatumumab, including patients with high-risk disease and disease previously refractory to ofatumumab. Full Article
progress Advanced ADC Histogram, Perfusion, and Permeability Metrics Show an Association with Survival and Pseudoprogression in Newly Diagnosed Diffuse Intrinsic Pontine Glioma: A Report from the Pediatric Brain Tumor Consortium [FUNCTIONAL] By www.ajnr.org Published On :: 2020-04-09T06:30:48-07:00 BACKGROUND AND PURPOSE: Diffuse intrinsic pontine glioma is a lethal childhood brain cancer with dismal prognosis and MR imaging is the primary methodology used for diagnosis and monitoring. Our aim was to determine whether advanced diffusion, perfusion, and permeability MR imaging metrics predict survival and pseudoprogression in children with newly diagnosed diffuse intrinsic pontine glioma. MATERIALS AND METHODS: A clinical trial using the poly (adenosine diphosphate ribose) polymerase (PARP) inhibitor veliparib concurrently with radiation therapy, followed by maintenance therapy with veliparib + temozolomide, in children with diffuse intrinsic pontine glioma was conducted by the Pediatric Brain Tumor Consortium. Standard MR imaging, DWI, dynamic contrast-enhanced perfusion, and DSC perfusion were performed at baseline and approximately every 2 months throughout treatment. ADC histogram metrics of T2-weighted FLAIR and enhancing tumor volume, dynamic contrast-enhanced permeability metrics for enhancing tumors, and tumor relative CBV from DSC perfusion MR imaging were calculated. Baseline values, post-radiation therapy changes, and longitudinal trends for all metrics were evaluated for associations with survival and pseudoprogression. RESULTS: Fifty children were evaluable for survival analyses. Higher baseline relative CBV was associated with shorter progression-free survival (P = .02, Q = 0.089) and overall survival (P = .006, Q = 0.055). Associations of higher baseline mean transfer constant from the blood plasma into the extravascular extracellular space with shorter progression-free survival (P = .03, Q = 0.105) and overall survival (P = .03, Q = 0.102) trended toward significance. An increase in relative CBV with time was associated with shorter progression-free survival (P < .001, Q < 0.001) and overall survival (P = .004, Q = 0.043). Associations of longitudinal mean extravascular extracellular volume fraction with progression-free survival (P = .03, Q = 0.104) and overall survival (P = .03, Q = 0.105) and maximum transfer constant from the blood plasma into the extravascular extracellular space with progression-free survival (P = .03, Q = 0.102) trended toward significance. Greater increases with time were associated with worse outcomes. True radiologic progression showed greater post-radiation therapy decreases in mode_ADC_FLAIR compared with pseudoprogression (means, –268.15 versus –26.11, P = .01.) CONCLUSIONS: ADC histogram, perfusion, and permeability MR imaging metrics in diffuse intrinsic pontine glioma are useful in predicting survival and pseudoprogression. Full Article
progress Jurassic Fossil Reveals Violent Squid Attack in Progress By feedproxy.google.com Published On :: Thu, 07 May 2020 18:14:00 +0000 An international team of paleontologists from the University of Plymouth, the University of Kansas and the Forge Fossils has found a specimen of the squid-like cephalopod Clarkeiteuthis montefiorei preserved with the herring-like fish Dorsetichthys bechei in its two arms; the bones in the head of the fish are broken in a manner that suggests a [...] Full Article Paleontology Cephalopod Clarkeiteuthis Clarkeiteuthis montefiorei Coleoidea Dorsetichthys bechei England Fish Jurassic Squid United Kingdom
progress Biden appeals to progressive groups to unite party By www.nbcnews.com Published On :: Wed, 06 May 2020 13:53:30 GMT Joe Biden's campaign is gaining the support of key progressive groups to unite the party's factions. Full Article
progress Regina Pats expecting forward progress By leaderpost.com Published On :: Sat, 09 May 2020 13:00:17 +0000 Rookie phenom Connor Bedard is the headliner of a workmanlike forward group that's looking to come of age with the Regina Pats. Full Article Regina Pats Hockey Connor Bedard Western Hockey League
progress UK 'must not ruin' coronavirus lockdown progress over Bank Holiday weekend as Boris Johnson 'rests up' after leaving intensive care By www.standard.co.uk Published On :: 2020-04-10T07:58:00Z Follow our live Covid-19 updates HERE Coronavirus: The symptoms Full Article
progress Hard Brexit more likely because of coronavirus and lack of progress in talks, says German foreign minister By news.yahoo.com Published On :: Fri, 08 May 2020 22:57:40 -0400 A hard Brexit is more likely due to the coronavirus crisis because Britain and the European Union have made so little progress in talks, Germany's foreign minister has said. Heiko Maas said that negotiations between Britain and the EU so far on the future trade relationship had yielded few gains with the UK disregarding the political declaration, which he said was "simply not on". Britain left the EU in January, and talks with the bloc are now focused on setting new trading terms from 2021, when London's status-quo transition period ends. However, the talks quickly hit an impasse when negotiations resumed last month, according to diplomats and officials. "It's worrying that Britain is moving further away from our jointly agreed political declaration on key issues in the negotiations," Mr Maas told the Augsburger Allgemeine newspaper. "It's simply not on, because the negotiations are a complete package as it's laid out in the political declaration." Mr Maas said there was currently neither common ground on how to shape a comprehensive trade deal or on whether to extend the negotiation period beyond the end of the year. "The British government is still refusing to extend the deadline," Mr Maas said. "If it stays that way, we will have to deal with Brexit in addition to the coronavirus at the turn of the year." Simon Coveney, Ireland's foreign minister, said on Friday that the coronavirus pandemic had made an already difficult timeline for a British-European Union trade deal "virtually impossible" and that it would make sense to seek more time. Full Article
progress 'Real and significant' progress being made but 'too early' to lift lockdown, Nicola Sturgeon says By www.standard.co.uk Published On :: 2020-04-30T11:57:00Z It is "too early" to begin easing any lockdown measures "in any meaningful way", Nicola Sturgeon has said. Full Article
progress French Education Minister Says School Reopenings Will Be Done 'Very Progressively' By www.npr.org Published On :: Fri, 08 May 2020 16:39:04 -0400 France's minister of education, Jean-Michel Blanquer, talked with NPR about the gradual reopening of schools, which will be voluntary. Still, many parents and administrators are against the plan. Full Article
progress Marko Grujic concedes he may need to leave Liverpool this summer to progress his career By www.standard.co.uk Published On :: 2020-04-11T13:04:56Z Marko Grujic has conceded that he may need to move on from Liverpool this summer if he is to fulfil his potential. Full Article
progress Independent senator defects to the Progressives as senators spar over committee seats By www.cbc.ca Published On :: Fri, 8 May 2020 15:40:13 EDT Manitoba Sen. Patricia Bovey has left the Independent Senators Group (ISG) and will now sit as a member of the Progressive caucus, a group composed of former Liberal senators. Full Article News/Politics
progress Coronavirus antibody tests are still a work in progress By www.latimes.com Published On :: Tue, 28 Apr 2020 17:54:54 -0400 Infectious disease experts are raising questions about the reliability of early coronavirus antibody tests and studies that hinge on their results. Full Article
progress Crescendo links with CRUK to progress cancer therapy By www.pharmatimes.com Published On :: Tue, 05 May 2020 10:23:22 +0100 The charity's Centre for Drug Development will sponsor and fund a future Phase I clinical trial for CB213 Full Article
progress European progress in long path for Lokelma By www.thepharmaletter.com Published On :: Tue, 05 May 2020 10:08:00 +0100 The European medicines regulator has OK’d a label update for AstraZeneca’s Lokelma (sodium zirconium… Full Article AstraZeneca/Biotechnology/Cardio-vascular/Drug Trial/Europe/European Medicines Agency/Focus On/Lokelma/Regulation/Research/UK
progress Remarks as Prepared for Delivery by Attorney General Eric Holder at the “Progress Through Prosperity” Dinner with President Leonel Fernandez By www.justice.gov Published On :: Mon, 14 Nov 2011 18:14:14 EST "It is in this spirit of friendship that I have traveled to your beautiful country. And I am grateful, on a very personal level, for this opportunity to help build upon the progress that our nations – and America’s allies throughout the Caribbean region – have made together over the years," said Attorney General Holder. Full Article Speech
progress Attorney General Eric Holder Speaks at Drug Court Commencement and Phase Progression Recognition Ceremony By www.justice.gov Published On :: Thu, 24 May 2012 10:11:58 EDT "My colleagues and I across the Justice Department – and the entire Obama Administration – remain deeply committed to expanding this work through funding grants, training, and other forms of assistance. We’re eager to continue partnering with leading jurists like those who serve this Court, tireless advocates like our allies at the PSA and NADCP, and determined drug court participants like each of you," said Attorney General Holder. Full Article Speech
progress Justice Department Concludes That Los Angeles County Jails System Has Made Progress, but Serious Deficiencies Continue By www.justice.gov Published On :: Fri, 6 Jun 2014 14:14:39 EDT The Justice Department today released its latest compliance assessment of mental health services at the Los Angeles County Jails based on a memorandum of agreement designed to protect the constitutional rights of prisoners with serious mental illness at the jails. Full Article OPA Press Releases
progress Associate Attorney General Tony West Delivers Remarks at the Progressive National Baptist Convention By www.justice.gov Published On :: Tue, 5 Aug 2014 11:43:35 EDT "Because if a government of, by and for the people means anything at all, it means that a ballot has the power to give equal voice to the high and the low; the weak and the strong; those at the bottom as well as the top. It means that in the polling place, the line is just as long for the richest among us as it is for those who often work the hardest but have the least." Full Article Speech
progress Molecular signatures of tumor progression in myxoid liposarcoma identified by <i>N</i>-glycan mass spectrometry imaging By feeds.nature.com Published On :: 2020-04-27 Full Article